Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)
- 2 May 2017
- journal article
- biotechnologically relevant-enzymes-and-proteins
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 101 (14) , 5645-5652
Abstract
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.Keywords
Funding Information
- National Science Foundation (1510895)
- National Science Foundation (1547518)
- National Institutes of Health (GM079688)
- National Institutes of Health (GM089866)
- National Institutes of Health (CA176854)
- Michigan State University
This publication has 43 references indexed in Scilit:
- Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergyMicrobial Cell Factories, 2011
- The yin and yang of neurotrophin actionNature Reviews Neuroscience, 2005
- ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand SortilinThe Journal of Neuroscience, 2005
- Mini ReviewGrowth Factors, 2004
- Production of Brain-Derived Neurotrophic Factor inEscherichia coliby Coexpression of Dsb ProteinsBioscience, Biotechnology, and Biochemistry, 2002
- Regulation of Cell Survival by Secreted ProneurotrophinsScience, 2001
- Activation loop tyrosines contribute varying roles to TrkB autophosphorylation and signal transductionOncogene, 1998
- Biological Activity of Brain-derived Neurotrophic Factor with Mismatched Disulfide Linkages Produced byEscherichia coliBioscience, Biotechnology, and Biochemistry, 1996
- Production of Biologically Active Mature Brain-derived Neurotrophic Factor inEscherichia coliBioscience, Biotechnology, and Biochemistry, 1995
- Purification and characterisation of a brain-derived neurotrophic factor/ neurotrophin-3 (BDNF/NT-3) heterodimerEuropean Journal of Biochemistry, 1994